FDA Reassessing Off-Label Policies To Address First Amendment Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
Guidance on scientific exchange is on the horizon; agency “carefully evaluating” existing advertising policies following recent court decisions.